GM-CSF expression has been found, frequently together with the GM-CSF receptor, in a variety of tumor models, including small-cell lung carcinomas [26], meningiomas [27], skin carcinoma [28], gliomas [29], and head and neck squamous cell carcinomas (HNSCCs) [30]. This evidence concerns the gene CSF2 and meningioma.